A CRISPR/dCasX‐mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c‐MYC or activating TP53

• Congcong Cao,
• Lin Yao,
• Aolin Li,
• Quan Zhang,
• Zhenan Zhang,
• Xiaofei Wang,
• Ying Gan,
• Yuchen Liu,
• Qian Zhang

Affiliations

Congcong Cao

Department of Urology Peking University First Hospital Beijing China

Lin Yao

Department of Urology Peking University First Hospital Beijing China

Aolin Li

Department of Urology Peking University First Hospital Beijing China

Quan Zhang

Department of Urology Peking University First Hospital Beijing China

Zhenan Zhang

Department of Urology Peking University First Hospital Beijing China

Xiaofei Wang

Department of Urology Peking University First Hospital Beijing China

Ying Gan

Department of Urology Peking University First Hospital Beijing China

Yuchen Liu

Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors Shenzhen Institute of Translational Medicine, Shenzhen Second People's Hospital The First Affiliated Hospital of Shenzhen University Shenzhen China

Qian Zhang

Department of Urology Peking University First Hospital Beijing China